Send us Fan Mail

The fitness industry makes money when you fail. Troy Taylor spent 20 years at the top of Olympic sport, and now he's the reason Tonal keeps 99% of its members while the rest of the industry churns through them like a revolving door.

He and Kevin don't talk about motivation. They talk about why motivation is the wrong thing to chase, what the actual data says about how people build a training habit that sticks, and why everything you've been told about starting a fitness program is probably backwards.

"It doesn't matter whether you start high or low. What mattered was a little more in week two, a little more in week three, a little more in week four."

Troy worked with Mikaela Shiffrin and Lindsey Vonn. The thing that made them exceptional? They showed up more than everyone else and worked on the things they were bad at. That's it. No secret sauce.

The same principle wrecks most people's January gym resolution, and the data proves it.

This one covers the behavioral science behind exercise adherence, why your first week should be embarrassingly easy, how an hour a week of lifting might be all you need, and what a VP of Performance Innovation actually does when he has 10 minutes and a deadline.

Find Troy at @StrengthScienceTroy on Instagram and learn more about Tonal at tonal.com.

Instagram: @kevinwhitemd

YouTube: @kevinwhitemd

Prime Health Associates

Send us Fan Mail

Last Friday, President Trump signed an executive order directing the FDA to fast-track psychedelic medicines for mental health treatment. Joe Rogan texted him about Ibogaine. The president texted back. Fifty million federal dollars followed.

You can have a lot of feelings about how that happened.

Here is what is not political: a small group of neuroscientists and psychiatrists spent the last decade quietly building the scientific case that certain psychedelic compounds can do something no pill or therapy has ever done. Dr. David Rabin is one of them. He has been training clinicians, treating veterans with PTSD that responded to nothing, and running what has been called the largest controlled study of psychedelic medicines in the world. He published a paper in 2023 showing that MDMA assisted therapy produces measurable changes in the DNA of PTSD patients, at the level of the cortisol receptor, in direct proportion to how much better they got.

Washington just showed up to a party that started ten years ago.

Dr. Kevin White sits down with Dr. Rabin to talk about what MDMA is actually doing in the brain, why the safety hypothesis changes how you think about stress and chronic illness, what Ibogaine does to opioid receptors that nothing else can, and why most of the ketamine being prescribed right now is being given wrong.

"Psychedelic medicines are to mental illness what antibiotics were to infection in the first half of the 20th century."

The science was already there. Now find out what it actually says.

Find more from Dr. Rabin at drdave.io and apolloneuro.com. Try the Apollo wearable at wearablehugs.com. His first book, A Simple Guide To Being Alive, is available at asimpleguidetobeingalive.com

Follow The Daily Apple and leave a review to help more people find the show.

Instagram: @KevinWhiteMD

YouTube: @KevinWhiteMD

www.primehealthassociates.com

Prime Health Associates

Send us Fan Mail

Most pet owners trust that regular vet visits, decent food, and a joint supplement are enough. Dr. Kevin Toman spent 35 years practicing that model. He doesn't believe it anymore.

After four decades in clinical medicine, a personal MGUS diagnosis that pushed him toward integrative care, and a growing awareness of how poorly the profession was serving aging pets, he rebuilt his practice entirely around longevity. He now runs one of the only concierge veterinary practices in the country focused on extending healthspan, not just managing disease.

If you don't have a pet, stay with this one. The conversation keeps landing back in the same place: the principles driving longevity in dogs and cats are the same ones driving it in humans. Rapamycin, caloric restriction, early cancer diagnostics, dental inflammation as a systemic disease driver, the failure of reactive medicine. Dr. Toman is applying an identical framework to a different patient population, and in some cases the data is cleaner because the studies are easier to run.

Dr. Kevin White sits down with Dr. Toman to cover rapamycin's role in preventing and treating cancer in dogs and cats, why he's using it preventively in asymptomatic patients, why glucosamine and chondroitin don't work and what the research actually supports, how breed-specific risk changes everything about how a patient should be managed, the cancer navigation crisis facing pet owners in rural areas, and where early cancer diagnostics are heading for both species.

"The relationships and the holistic care that are so important to lifestyle and longevity have disappeared from the veterinary lexicon."

This one covers more ground than most pet health conversations get anywhere near.

Find more from Dr. Toman at helpingpetslivelonger.com and freevetcall.com

And follow The Daily Apple and leave a review to help more people find the show.

Instagram: @KevinWhiteMD

YouTube: @KevinWhiteMD

www.primehealthassociates.com

Prime Health Associates